Lonza will produce clinical trial and commercial supplies of Osiris Therapeutics' adult stem cell therapy, Prochymal. Lonza will build new facilities in Walkersville, including the first commercial-scale allogeneic cGMP manufacturing facility and capacity to manufacture cGMP grade cell culture media for therapeutic applications.
Forbes
Wednesday 2 July 2008
Lonza commits to stem cells
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment